Left-dominant arrhythmogenic cardiomyopathy: an under-recognized clinical entity.

By S. Sen‐Chowdhry, P. Syrris, S. Prasad, S. Hughes, Robert D. Merrifield, Deirdre Ward, D. Pennell, W. McKenna. Journal of the American College of Cardiology, 2008

648 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Rheumatology

View Paper: https://www.semanticscholar.org/paper/ec63fcd251ba8a58875810ab6fe12b941e6b2840

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. D. Corrado
2. H. Tandri
3. G. Thiene
4. Frank I. Marcus
5. R. Hauer
6. A. Nava
7. W. McKenna
8. Jonathan S. Steinberg

Citations in the corpus

• 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the preventionof sudden cardiac death (2015, neutral): “50% of patients.(384) Current task force criteria use histological, genetic, electrocardiographic and imaging parameters to classify patients into definite, borderline and possible diagnostic categories.”
• Dilated Cardiomyopathy (2007, neutral): “Affected patients may present with an increased burden of ventricular tachyarrhythmia and/or coarse hair with palmoplantar hyperkeratosis (cardiocutaneous syndrome).(27) Autosomal recessive cardiocutaneous syndrome with primary LV involvement is termed Carvajal syndrome,(28) although autosomal domin”
• Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. (2010, positive): “Nevertheless, endomyocardial biopsy may identify other conditions (e.g. myocarditis, sarcoidosis, endomyocardial fibrosis), and the recognition of myocyte loss with fibrous or fibrofatty replacement can be a valuable diagnostic feature.46 The identification of disease-causing genes has led to the re”